source
- AstraZeneca reports Tagrisso-Orpathys combo could prolong treatment for EGFR-mutant lung cancerAt the European Society for Medical Oncology meeting, AstraZeneca said early data suggest that adding Orpathys to Tagrisso may let patients with mutant non‑small cell lung cancer continue therapy a…
- #ESMO26: Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work beginsMADRID — In a testament to clinicians’ interest in Merck and Moderna’s personalized cancer vaccine data at this year’s European Society for Medical Oncology conference, the presidential symposium,…Endpoints · 15d ago↗ source